![](/img/cover-not-exists.png)
LBP-24-Safety, tolerability and efficacy of volixibat, an apical sodium-dependent bile acid transporter inhibitor, in adults with nonalcoholic steatohepatitis: 24-week interim analysis results from a phase 2 study
Newsome, Philip, Palmer, Melissa, Freilich, Bradley, Sheikh, Muhammad, Sheikh, Aasim, Sarles, Harry, Herring, Robert, Mantry, Parvez, Kayali, Zeid, Hassanein, Tarek, Chen, Yi, Aithal, GuruprasadVolume:
70
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0618-8278(19)30270-1
Date:
April, 2019
File:
PDF, 781 KB
english, 2019